MLB

Ronald Acuña Jr. Hits the Injured List With Grade 1 Hamstring Strain

The Atlanta Braves got the diagnosis nobody wanted. Ronald Acuña Jr. was placed on the 10-day injured list after an MRI confirmed a Grade 1 right hamstring strain. The 28-year-old outfielder pulled up running out a ground ball over the weekend and immediately knew something was off. Grade 1 is the mildest hamstring grade, which is the good news. The bad news is that hamstring injuries do not heal on hard timetables.

The Braves have been waiting for Acuña to get fully healthy for two years. He tore his ACL in May of 2024 and missed the rest of that season. He came back in 2025 and put up MVP-caliber numbers when he played, but he also dealt with various minor injuries that limited him to 122 games. Through 41 games in 2026, he was finally looking like the 2023 version again, hitting .328 with 9 homers and 11 stolen bases.

This hamstring is the latest setback. Grade 1 strains typically require two to four weeks of recovery. The Braves are saying he will be re-evaluated in two weeks. The realistic expectation is that he misses three to four weeks before he is back in the lineup.

The Braves can absorb the absence, but it hurts. Atlanta is 22-19, sitting in third place in the NL East behind the Phillies and Mets. They need every game they can get. Acuña is the best player on the team, the engine of the offense, and the guy who turns a good lineup into an elite one. Without him, the Braves are merely good.

The bigger concern is Acuña himself. He has come back from a torn ACL in his right knee and is now dealing with a strain in the same leg. Hamstring issues in surgically repaired knees can be ongoing problems. The Braves medical staff is going to be careful with this rehab. Acuña is too important to push him back at 80 percent.

The Atlanta lineup without him is still solid. Matt Olson and Austin Riley are middle-of-the-order bats. Sean Murphy provides power from the catcher position. Ozzie Albies has been solid at second base. But the player who turned the Braves into a juggernaut from 2021 to 2023 is the one who is missing.

The replacement plan is going to be a committee. Eli White will get more time in right field. Jarred Kelenic, who was waived by Atlanta last year and re-signed in spring training, gets another chance. Forrest Wall could see some major league time. None of them are Acuña, but they can cover for two to four weeks without disaster.

The bigger Braves picture is that the offense has been inconsistent all year. They have stretches where they score 12 runs and stretches where they score 4 in a four-game span. The lineup has too many strikeouts and not enough on-base ability behind Acuña. When he is hot, none of that matters. When he is on the IL, it all matters.

The pitching staff is fine. Spencer Strider has been mostly healthy and pitching like an ace. Charlie Morton continues to defy aging. Reynaldo Lopez has been the surprise of the rotation. The bullpen has been one of the best in the National League. The Braves can hold their own in low-scoring games. They just need the offense to wake up.

The other angle on this is that Acuña is in the third year of his eight-year, $100 million extension. That contract looked absurdly team-friendly when he was healthy. It still does, even with the injury history. The Braves have one of the most talented players in baseball under control through 2028 at well below market value.

For now, Atlanta has to ride the storm. Acuña is going to be back. The hamstring is mild. The bigger window is still wide open. But the Braves have less margin than they would like, and every series matters in a division that has the Phillies, Mets, and Marlins all playing well. The next month is going to be tough sledding.

Carlos Garcia

A longtime sports reporter, Carlos Garcia has written about some of the biggest and most notable athletic events of the last 5 years. He has been credentialed to cover MLS, NBA and MLB games all over the United States. His work has been published on Fox Sports, Bleacher Report, AOL and the Washington Post.
Back to top button